Agency Information Collection Activities: Proposed Collection; Comments Requested, 11443 [E8-3954]

Download as PDF Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices definitions of the Domestic Like Product and Domestic Industry; if you disagree with either or both of these definitions, please explain why and provide alternative definitions. Authority: This review is being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.61 of the Commission’s rules. By order of the Commission. Issued: February 26, 2008. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E8–3973 Filed 2–29–08; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0010] Agency Information Collection Activities: Proposed Collection; Comments Requested 60-Day Notice of Information Collection Under Review—U.S. Official Order Forms for Schedule I and II Controlled Substances (Accountable Forms), Order Form Requisition DEA Form 222 and 222a. rmajette on PROD1PC64 with NOTICES ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until May 2, 2008. This process is conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including VerDate Aug<31>2005 15:33 Feb 29, 2008 Jkt 214001 whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this Information Collection: (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: U.S. Official Order Forms for Schedule I and II Controlled Substances (Accountable Forms), Order Form Requisition (DEA Form 222 and 222a). (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: DEA Form 222 and 222a. Component: Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: Not-for-profit, State, local or tribal government. Abstract: DEA–222 is used to transfer or purchase Schedule I and II controlled substances and data are needed to provide an audit of transfer and purchase. DEA–222a Requisition Form is used to obtain the DEA–222 Order Form. Persons may also digitally sign and transmit orders for controlled substances electronically, using a digital certificate. Orders for Schedule I and II controlled substances are archived and transmitted to DEA. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that 96,280 registrants submit forms annually for this collection, taking an estimated 13.34 hours annually. (6) An estimate of the total public burden (in hours) associated with the collection: DEA estimates that there will be 1,283,935 annual burden hours associated with the collection. If additional information is required contact: Lynn Bryant, Department PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 11443 Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street NW., Washington, DC 20530. Dated: February 26, 2008. Lynn Bryant, Department Clearance Officer, PRA, Department of Justice. [FR Doc. E8–3954 Filed 2–29–08; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0021] Agency Information Collection Activities: Proposed Collection; Comments Requested 60-Day Notice of Information Collection Under Review Records and Reports of Registrants. ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until May 2, 2008. This process is conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; E:\FR\FM\03MRN1.SGM 03MRN1

Agencies

[Federal Register Volume 73, Number 42 (Monday, March 3, 2008)]
[Notices]
[Page 11443]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-3954]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0010]


Agency Information Collection Activities: Proposed Collection; 
Comments Requested

ACTION: 60-Day Notice of Information Collection Under Review--U.S. 
Official Order Forms for Schedule I and II Controlled Substances 
(Accountable Forms), Order Form Requisition DEA Form 222 and 222a.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA), will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. Comments are encouraged and will be accepted 
until May 2, 2008. This process is conducted in accordance with 5 CFR 
1320.10.
    If you have comments, especially on the estimated public burden or 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact Mark W. Caverly, Chief, Liaison and Policy 
Section, Office of Diversion Control, Drug Enforcement Administration, 
Washington, DC 20537.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.
    Overview of this Information Collection:
    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: U.S. Official Order Forms for 
Schedule I and II Controlled Substances (Accountable Forms), Order Form 
Requisition (DEA Form 222 and 222a).
    (3) Agency form number, if any, and the applicable component of the 
Department sponsoring the collection:
    Form number: DEA Form 222 and 222a.
    Component: Office of Diversion Control, Drug Enforcement 
Administration, Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: Not-for-profit, State, local or tribal government.
    Abstract: DEA-222 is used to transfer or purchase Schedule I and II 
controlled substances and data are needed to provide an audit of 
transfer and purchase. DEA-222a Requisition Form is used to obtain the 
DEA-222 Order Form. Persons may also digitally sign and transmit orders 
for controlled substances electronically, using a digital certificate. 
Orders for Schedule I and II controlled substances are archived and 
transmitted to DEA.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that 96,280 registrants submit forms annually for this collection, 
taking an estimated 13.34 hours annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: DEA estimates that there will be 1,283,935 annual 
burden hours associated with the collection.
    If additional information is required contact: Lynn Bryant, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Patrick Henry 
Building, Suite 1600, 601 D Street NW., Washington, DC 20530.

    Dated: February 26, 2008.
Lynn Bryant,
Department Clearance Officer, PRA, Department of Justice.
 [FR Doc. E8-3954 Filed 2-29-08; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.